Experts related to Understanding, Preventing and Treating Opioid Abuse
Dr. Eric Otto Johnson is currently leading several major studies regarding opioid addiction and HIV focused on gene discovery, gene regulation, and integrative ‘omics.
Beth Lasater’s work emphasizes IT in public health, health informatics, health policy, and assessment. She has been involved in many studies relating to maternal and child health.
Jennie Harris is currently the associate project director for an FDA study to determine the feasibility of making naloxone—a drug to treat opioid overdoses.
William Zule, DrPH, is a leading expert in community-based HIV prevention research. He has researched assessing treatment readiness and entry among out-of-treatment drug users.
Dr. Scott Runyon leads RTI’s synthetic medicinal chemistry research. His lab is developing small-molecule agonists for neuropeptide S and the APJ GPCR’s.
Dr. Elvira Elek’s work focuses on evaluating federally-funded, community-level substance abuse prevention programs, including opioid use prevention programs.
Dr. R. Craig Lefebvre, is an expert in public health and social change programs focusing on health, financial literacy and social well-being.
Dr. Yanan Zhang’s current research applies to drug addiction and pain management, including orexin, cannabinoid and neuropeptide FF (NPFF) receptors.
Joshua Richardson is an expert researcher in digital health and clinical informatics and contributes to projects that leverage and evaluate health IT and data.
Gary A. Zarkin, PhD, has led or participated in many projects involving the economic analysis of drug treatment, prevention, and studies of workplace substance abuse.
Ann M. Decker, Ph.D., conducts preclinical in vitro research to characterize novel compounds at CNS G-protein coupled receptors and biogenic amine transporters.
Dr. Kevin Conway is the author of over 70 peer-reviewed articles and book chapters focusing on the epidemiology of alcohol, tobacco, drug use including opioid use, co-occurring psychiatric disorders, and violence.
Dr. Laura Dunlap, is experienced in econometric analysis and evaluations of substance abuse interventions focusing on heroin, methadone treatment, and opioids.
Dr. P. Anantha Reddy studies peptide synthesis at RTI, supported by the National Institute on Drug Abuse (NIDA).
Claudia Squire conducts research on health communications topics spanning substance use, direct-to-consumer prescription drug advertising, and a variety of chronic conditions.
Lauren McCormack, PhD, MSPH, focuses on promoting informed health decision making through effective communication and measuring and evaluating the impact information.
Dr. Laurie Cluff is a psychologist who has evaluated interventions and developed targeted screening tools directed at preventing workplace drug abuse.
Bryan R. Garner, senior implementation research scientist, uses experimental psychology to inform his work on substance use disorders.
Dr. Ivy Carroll has made major scientific contributions in drug discovery potential treatments for cocaine, opioid and nicotine addictions.
Dr. John Morgan is internationally recognized for his work in forensics, body armor, special operations technology, and predictive policing.